Interferon-α nasal spray was safe and effective in reducing COVID-19 risk by 40% in patients with cancer, demonstrating its potential as an additional preventive strategy alongside vaccines and ...
Nasal drug delivery is now emerging as a promising route for the rapid delivery of certain classes of molecules.
Scientists believe that medication given through the nose has the potential to be more effective because it attacks or blocks the virus at the source.
Researchers say people using a common allergy nasal spray, azelastine, were 69% less likely to contract COVID-19. Participants in the trial were additionally 71% less likely to catch the common cold ...
Researchers discuss the effects of azelastine nasal spray on the rate of SARS-CoV-2 infection as compared to placebo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback